Matthew E Callister
Overview
Explore the profile of Matthew E Callister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murray R, Alexandris P, Baldwin D, Brain K, Britton J, Crosbie P, et al.
Eur Respir J
. 2024 Apr;
63(4).
PMID: 38636970
Background: Up to 50% of those attending for low-dose computed tomography screening for lung cancer continue to smoke and co-delivery of smoking cessation services alongside screening may maximise clinical benefit....
2.
Murray R, Evison M, Callister M
Eur Respir Rev
. 2022 Nov;
31(166).
PMID: 36323419
No abstract available.
3.
Li M, Zhang L, Charvat H, Callister M, Sasieni P, Christodoulou E, et al.
Int J Cancer
. 2022 Jul;
151(9):1491-1501.
PMID: 35809038
We aimed to explore the underlying reasons that estimates of overdiagnosis vary across and within low-dose computed tomography (LDCT) lung cancer screening trials. We conducted a systematic review to identify...
4.
Davies N, Callister M, Copeland H, Griffiths S, Holtam L, Lambert P, et al.
Int J Environ Res Public Health
. 2022 Jul;
19(13).
PMID: 35805380
Smoking cessation services have rapidly transformed during the COVID-19 pandemic. Changes include pivoting from face-to-face to telephone and video call support, remote provision of stop smoking aids and more flexible...
5.
Gilbert F, Harris S, Miles K, Weir-McCall J, Qureshi N, Rintoul R, et al.
Health Technol Assess
. 2022 Mar;
26(17):1-180.
PMID: 35289267
Background: Current pathways recommend positron emission tomography-computerised tomography for the characterisation of solitary pulmonary nodules. Dynamic contrast-enhanced computerised tomography may be a more cost-effective approach. Objectives: To determine the diagnostic...
6.
Bartlett E, Silva M, Callister M, Devaraj A
J Thorac Oncol
. 2021 Feb;
16(6):912-921.
PMID: 33545386
Identifying false-negative cases is an important quality metric in lung cancer screening, but it has been infrequently and variably reported in previous studies. Although as a proportion of all screening...
7.
Baldwin D, Callister M, Crosbie P, ODowd E, Rintoul R, Robbins H, et al.
Eur Respir J
. 2021 Jan;
57(1).
PMID: 33446580
No abstract available.
8.
Neal R, Sun F, Emery J, Callister M
BMJ
. 2019 Jun;
365:l1725.
PMID: 31160279
No abstract available.
9.
Oke J, Pickup L, Declerck J, Callister M, Baldwin D, Gustafson J, et al.
Diagn Progn Res
. 2019 May;
2:22.
PMID: 31093569
Introduction: Lung cancer is a common cancer, with over 1.3 million cases worldwide each year. Early diagnosis using computed tomography (CT) screening has been shown to reduce mortality but also...
10.
Jones C, Brunelli A, Callister M, Franks K
Curr Surg Rep
. 2018 Feb;
6(2):5.
PMID: 29456881
Purpose Of Review: The majority of patients with non-small cell lung cancer (NSCLC) present with advanced disease and overall survival rates are poor. This article outlines the current and outstanding...